Hartig Monika B, Hörtnagel Konstanze, Garavaglia Barbara, Zorzi Giovanna, Kmiec Tomasz, Klopstock Thomas, Rostasy Kevin, Svetel Marina, Kostic Vladimir S, Schuelke Markus, Botz Evelyn, Weindl Adolf, Novakovic Ivana, Nardocci Nardo, Prokisch Holger, Meitinger Thomas
Institute of Human Genetics, GSF-National Research Center for Environment and Health, Neuherberg, Germany.
Ann Neurol. 2006 Feb;59(2):248-56. doi: 10.1002/ana.20771.
Neurodegeneration with brain iron accumulation (NBIA) is a group of disorders characterized by magnetic resonance imaging (MRI) changes in basal ganglia. Both missense and nonsense mutations have been found in such patients in a gene encoding the mitochondrial pantothenate kinase (PANK2).
We completed a mutation screen in 72 patients with the diagnosis NBIA based on clinical findings and radiological imaging. The entire coding region of the PANK2 gene (20p12.3) was investigated for point mutations and deletions.
We uncovered both mutant alleles in 48 patients. Deletions accounted for 4% of mutated alleles. Patients with two loss-of-function alleles (n = 11) displayed symptoms always at an early stage of life. In the presence of missense mutations (n = 37), the age of onset correlated with residual activity of the pantothenate kinase. Progression of disease measured by loss of ambulation was variable in both groups. We did not observe a strict correlation between the eye-of-the-tiger sign and PANK2 mutations. In 24 patients, no PANK2 mutation was identified.
Deletion screening of PANK2 should be part of the diagnostic spectrum. Factors other than enzymatic residual activity are determining the course of disease. There are strong arguments in favor of locus heterogeneity.
脑铁沉积神经变性病(NBIA)是一组以基底节磁共振成像(MRI)改变为特征的疾病。在这类患者中,编码线粒体泛酸激酶(PANK2)的基因中已发现错义突变和无义突变。
我们基于临床发现和影像学检查,对72例诊断为NBIA的患者进行了突变筛查。研究了PANK2基因(20p12.3)的整个编码区的点突变和缺失情况。
我们在48例患者中发现了两个突变等位基因。缺失占突变等位基因的4%。具有两个功能丧失等位基因的患者(n = 11)总是在生命早期出现症状。在存在错义突变的患者中(n = 37),发病年龄与泛酸激酶的残余活性相关。两组中通过行走能力丧失来衡量的疾病进展情况各不相同。我们未观察到“虎眼征”与PANK2突变之间存在严格的相关性。在24例患者中,未发现PANK2突变。
PANK2基因的缺失筛查应成为诊断范围的一部分。除酶残余活性外的其他因素决定了疾病进程。有充分理由支持基因座异质性。